ECT, Research, and Professional Ambivalence
1998; American Psychiatric Association; Volume: 155; Issue: 1 Linguagem: Inglês
10.1176/ajp.155.1.1
ISSN1535-7228
Autores Tópico(s)Electroconvulsive Therapy Studies
ResumoBack to table of contents Next article EditorialFull AccessECT, Research, and Professional AmbivalenceCarl Salzman, M.D.Carl Salzman, M.D.Published Online:1 Jan 1998https://doi.org/10.1176/ajp.155.1.1AboutSectionsView EPUB ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinked InEmail Modern psychiatry is becoming a data-based scientific discipline. As in other branches of medicine, diagnoses stem from increasingly rigorously defined criteria, and treatment recommendations are based on the results of controlled clinical trials. The days of "impressionistic," seat-of-the-pants formulations and treatments are rapidly disappearing.Among psychiatric treatments, data for the efficacy of ECT, especially for the most severely depressed patients, are incontrovertible. Meta-analyses of ECT trials versus placebo, tricyclic or monoamine oxidase inhibitor antidepressants, or sham ECT convincingly demonstrate the efficacy of ECT (1). Use of modern anesthetic and ECT administration techniques has all but eliminated serious side effects. In addition, Olfson et al., in this issue of the Journal, have confirmed that ECT may lead to shorter and less costly inpatient care.Given this demonstrated efficacy, safety, and economic savings, one would assume that the use of ECT would be more uniform throughout the United States. Hermann et al. (2), however, have demonstrated that use of ECT varies widely and depends on geographic location, with some areas of the United States hardly administering the treatment at all! It is likely that psychiatric residents in some residency training programs may never even see an ECT treatment, let alone administer a treatment and witness its efficacy.If our psychiatric treatments are, indeed, based on the results of research, how, then, are we to account for the wide variability in ECT treatment in the United States? Despite the data, it appears that there continues to be ambivalence among American psychiatrists toward this efficacious and safe treatment. One reason may lie in its history of unmodified administration and the resultant side effects. Certainly films such as Shock Corridor,One Flew Over the Cuckoo's Nest, and Frances cannot have helped its reputation. However, there may be another more central reason for this ambivalence. With a few notable exceptions, there is little ECT research being conducted in major American psychiatric centers compared with research on pharmacological treatments. Many of the efficacy studies are one or more decades old. Rigorously designed multisite collaborative studies, using modern research techniques, of ECT's efficacy and predictors and correlates of response, relapse, and maintenance do not exist.It appears that ECT has failed to attract current scientific curiosity. Despite a journal devoted exclusively to convulsive therapy, and a society of dedicated researchers and clinicians, there has not been the same systematic accretion of clinical research into ECT's mechanisms and efficacy as there has been for antidepressants. Examination of articles published in the past 3 years in The American Journal of Psychiatry, for example, reveals not a single controlled study of efficacy or mechanisms of action. Without such studies, there cannot be adequate comparison among modern psychiatric treatments, nor can knowledge increase regarding pathogenesis of psychiatric illness, as well as its treatment.What is to be done? We lack comparisons of ECT's efficacy with adequately dosed trials of new antidepressants for all categories of depression, especially for our sickest patients. We need carefully collected data on the therapeutic impact of ECT for the suicidally depressed patient, both acutely and after treatment. Direct comparisons of long-term outcome, cost, and safety of ECT with pharmacological treatment are essential. In an effort to understand its therapeutic mechanisms, new research strategies such as imaging studies conducted before, during, and after ECT in depressed patients of all ages should be performed. Using modern molecular biology techniques, we need inquiry into acute and chronic effects of ECT on basic mechanisms of synaptic and second messenger function, neuronal adaptation, long-term plasticity, and hormonal response.There is much fascinating research to conduct, if we can only overcome a professional ambivalence toward ECT and ignite the imagination and enthusiasm of our trainees and young research colleagues. Let us not perpetuate outmoded, nonscientific, and incorrect attitudes toward ECT in our younger colleagues. Rather, let us stimulate scientific curiosity and research into this cost-effective and safe psychiatric treatment.Address reprint requests to Dr. Salzman, Consolidated Department of Psychiatry, Harvard Medical School, Massachusetts Mental Health Center, 74 Fenwood Ave., Boston, MA 02115.References1. Janicak PG, Davis JM, Preskorn SH, Ayd FJ Jr: Principles and Practice of Psychopharmacotherapy, 2nd ed. Baltimore, Williams & Wilkins, 1997, pp 373–374Google Scholar2. Hermann RC, Dorwart RA, Hoover CW, Brody J: Variation in ECT use in the United States. Am J Psychiatry 1995; 152:869–875Link, Google Scholar FiguresReferencesCited byDetailsCited byManaging the supportive care needs of those affected by COVID-198 April 2020 | European Respiratory Journal, Vol. 55, No. 4Benzodiazepines in anxiety disorders: Reassessment of usefulness and safety25 September 2018 | The World Journal of Biological Psychiatry, Vol. 20, No. 7Journal of Psychopharmacology, Vol. 33, No. 11Journal of Oriental Neuropsychiatry, Vol. 26, No. 3Social Work in Public Health, Vol. 28, No. 3-4Panic-Focused Psychodynamic Psychotherapy in a Woman with Panic Disorder and Generalized Anxiety DisorderHarvard Review of Psychiatry, Vol. 20, No. 5The role of alprazolam for the treatment of panic disorder in Australia5 January 2012 | Australian & New Zealand Journal of Psychiatry, Vol. 46, No. 3Social Psychiatry and Psychiatric Epidemiology, Vol. 47, No. 11Psychotherapeut, Vol. 57, No. 4Journal of EMDR Practice and Research, Vol. 6, No. 3The World Journal of Biological Psychiatry, Vol. 13, No. 2Comorbid Anxiety and Substance Use Disorders31 May 2012Journal of Clinical Psychopharmacology, Vol. 31, No. 2Are There Guidelines for the Responsible Prescription of Benzodiazepines?1 November 2010 | The Canadian Journal of Psychiatry, Vol. 55, No. 11The Practice of Electroconvulsive Therapy in AsiaThe Journal of ECT, Vol. 26, No. 1Journal of the Korean Medical Association, Vol. 53, No. 10A Study Demonstrating Efficacy of a Psychoanalytic Psychotherapy for Panic Disorder: Implications for Psychoanalytic Research, Theory, and Practice1 February 2009 | Journal of the American Psychoanalytic Association, Vol. 57, No. 1Journal of Clinical Psychopharmacology, Vol. 29, No. 3Current Opinion in Psychiatry, Vol. 22, No. 1International Clinical Psychopharmacology, Vol. 24, No. 1Persistent Depression and Anxiety in the United States: Prevalence and Quality of CareAlexander S. Young, M.D., M.S.H.S.Ruth Klap, Ph.D.Rebecca Shoai, M.P.H., M.S.W.Kenneth B. Wells, M.D., M.P.H.13 January 2015 | Psychiatric Services, Vol. 59, No. 12Social Psychiatry and Psychiatric Epidemiology, Vol. 43, No. 8Death Studies, Vol. 32, No. 4Cognitive Behaviour Therapy, Vol. 37, No. 3BMC Psychiatry, Vol. 8, No. 112-Month Follow-Up Study of Drug Treatment in Pathological GamblersJournal of Clinical Psychopharmacology, Vol. 27, No. 6A Questionnaire Survey of ECT Practice in AustraliaThe Journal of ECT, Vol. 23, No. 2Panic disorder in the elderlyAging Health, Vol. 3, No. 2Depression and Anxiety, Vol. 24, No. 1Psychopharmacology, Vol. 194, No. 2Early Intervention in Psychiatry, Vol. 1, No. 1Recurrence of Panic Disorder During PregnancyClinical Neuropharmacology, Vol. 29, No. 3European Archives of Psychiatry and Clinical Neuroscience, Vol. 256, No. 3New England Journal of Medicine, Vol. 354, No. 22Expert Review of Neurotherapeutics, Vol. 6, No. 2Expert Review of Neurotherapeutics, Vol. 6, No. 3ECT: Knowledge and attitude among patients and their relativesIndian Journal of Psychiatry, Vol. 48, No. 1Clinical management of depression and anxiety in HIV-infected adultsAIDS, Vol. 19, No. 18A placebo-controlled, randomized withdrawal study of sertraline for panic disorder in JapanInternational Clinical Psychopharmacology, Vol. 20, No. 5The Combined Use of Electroconvulsive Therapy and Antipsychotics in Patients With SchizophreniaThe Journal of ECT, Vol. 21, No. 2Hungarian Medical Students' Knowledge About and Attitudes Toward Electroconvulsive TherapyThe Journal of ECT, Vol. 21, No. 2Journal of Palliative Medicine, Vol. 8, No. 2Alcoholism: Clinical & Experimental Research, Vol. 29, No. 8Therapy, Vol. 2, No. 2The World Journal of Biological Psychiatry, Vol. 5, No. 4The Journal of ECT, Vol. 20, No. 3Epidemiology, Vol. 15, No. 2Verhaltenstherapie, Vol. 14, No. 4Expert Opinion on Pharmacotherapy, Vol. 5, No. 7Drugs & Therapy Perspectives, Vol. 20, No. 9Combined Paroxetine and Clonazepam Treatment Strategies Compared to Paroxetine Monotherapy for Panic Disorder1 July 2016 | Journal of Psychopharmacology, Vol. 17, No. 3Depression and Anxiety, Vol. 17, No. 2Current Psychiatry Reports, Vol. 5, No. 4British Journal of Psychiatry, Vol. 182, No. 1Drugs & Aging, Vol. 20, No. 12Human Psychopharmacology: Clinical and Experimental, Vol. 17, No. 8Biological Psychiatry, Vol. 52, No. 6Current Opinion in Psychiatry, Vol. 15, No. 2The Clinical Journal of Pain, Vol. 18, No. SupplementThe World Journal of Biological Psychiatry, Vol. 3, No. 4How Treating Psychoanalysts Respond To Psychotherapy Research Constraints19 May 2017 | Journal of the American Psychoanalytic Association, Vol. 49, No. 3Evidence-Based Pharmacologic Treatment for People With Severe Mental Illness:A Focus on Guidelines and AlgorithmsThomas A. Mellman, M.D., Alexander L. Miller, M.D., Ellen M. Weissman, M.D., M. Lynn Crismon, Pharm.D., Susan M. Essock, Ph.D., and Stephen R. Marder, M.D.1 May 2001 | Psychiatric Services, Vol. 52, No. 5Depression and Anxiety, Vol. 14, No. 2The Journal of ECT, Vol. 17, No. 2Panic Disorder in Primary Care: Patients' Attributions of Illness Causes and Willingness to Accept Psychiatric Treatment24 June 2016 | The International Journal of Psychiatry in Medicine, Vol. 30, No. 4The Journal of Nervous & Mental Disease, Vol. 188, No. 2Journal of the American Geriatrics Society, Vol. 48, No. 5Treatment of Corticosteroid-Induced Mood Changes With OlanzapineE. SHERWOOD BROWN, PH.D., M.D., DAVID A. KHAN, M.D., and TRISHA SUPPES, M.D., PH.D., 1 June 1999 | American Journal of Psychiatry, Vol. 156, No. 6Progress in ECT ResearchMATTHEW V. RUDORFER, M.D., and BARRY D. LEBOWITZ, PH.D., 1 June 1999 | American Journal of Psychiatry, Vol. 156, No. 6Journal of the American Academy of Child & Adolescent Psychiatry, Vol. 38, No. 5 Volume 155Issue 1 January 1998Pages 1-2 Metrics History Published online 1 January 1998 Published in print 1 January 1998
Referência(s)